Literature DB >> 4183130

Effects of L-dopa in Parkinson's disease.

R B Godwin-Austen, E B Tomlinson, C C Frears, H W Kok.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4183130     DOI： 10.1016/s0140-6736(69)91417-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  48 in total

1.  Assessment of drugs in schizophrenia. Asessment of drug-induced extrapyramidal reactions and of drugs given for their control.

Authors:  R H Mindham
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

Review 2.  Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.

Authors:  Khosro Jamebozorgi; Eskandar Taghizadeh; Daryoush Rostami; Hosein Pormasoumi; George E Barreto; Seyed Mohammad Gheibi Hayat; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-11-05       Impact factor: 5.590

3.  London letter.

Authors:  S S Gilder
Journal:  Can Med Assoc J       Date:  1970-05-09       Impact factor: 8.262

4.  L-dopa and arousal.

Authors:  T B Horvath; R A Meares
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

5.  Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias.

Authors:  H L Klawans; W J Weiner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

6.  Incidence of side effects from levodopa during the introduction of treatment.

Authors:  R B Godwin-Austen; C C Frears; S Bergmann
Journal:  Br Med J       Date:  1971-01-30

7.  The cardiovascular effects of L-dopa in the pithed rat.

Authors:  E Eden; P A Nasmyth
Journal:  Br J Pharmacol       Date:  1974-08       Impact factor: 8.739

8.  Cause of death among patients with Parkinson's disease: a rare mortality due to cerebral haemorrhage.

Authors:  S Iwasaki; Y Narabayashi; K Hamaguchi; A Iwasaki; M Takakusagi
Journal:  J Neurol       Date:  1990-04       Impact factor: 4.849

9.  Levodopa's awakening effect on patients with Parkinsonism.

Authors:  G G Marsh; C M Markham; R Ansel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-06       Impact factor: 10.154

10.  Effect of age and arteriosclerosis on the response of Parkinsonian patients to levodopa.

Authors:  R B Godwin-Austen; S Bergmann; C C Frears
Journal:  Br Med J       Date:  1971-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.